The FDA pausing use of J&J's vaccine is disappointing news, but the market reaction seems muted so far. We still have two other vaccines out there that seem to be working well. Meanwhile, today's inflation read looks pretty uneventful.
Onslaught Ahead: J&J Vaccine Pause Weighs Slightly Ahead Of Tomorrow's Bank Earnings
Forbes - 13 Apr 2021 15:27
The FDA pausing use of J&J's vaccine is disappointing news, but the market reaction seems muted so far. We still have two other vaccines out there that seem to be working well. Meanwhile, today's inflation read looks pretty uneventful.
Share this Article
Recommended